Wenzhou Celecare Medical Instruments Co.,Ltd
Wenzhou Celecare Medical Instruments Co., Ltd was founded in 2009 with registered capital of 6.3 million, an enterprise specializing in researching, developing and manufacturing medical products, which are popular with domestic and foreign customers. We have exported our products to the United States, India, the United Kingdom, France, South Korea, Turkey, Russia, Africa, South America and the Middle East etc... Our factory is located in Wenzhou city, covering 3, 100 square meters(1000 square meters for a 100, 000 class purification workshop), with more than 100 employees. We have got certificates related with the quality management system ISO13485,CE and FDA.We have been recognized and affirmed by customers at home and abroad, and achieved good reputation in the medical industry.
Wenzhou Celecare Medical Instruments Co.,Ltd
Wenzhou Celecare Medical Instruments Co., Ltd was founded in 2009 with registered capital of 6.3 million, an enterprise specializing in researching, developing and manufacturing medical products, which are popular with domestic and foreign customers. We have exported our products to the United States, India, the United Kingdom, France, South Korea, Turkey, Russia, Africa, South America and the Middle East etc... Our factory is located in Wenzhou city, covering 3, 100 square meters(1000 square meters for a 100, 000 class purification workshop), with more than 100 employees. We have got certificates related with the quality management system ISO13485,CE and FDA.We have been recognized and affirmed by customers at home and abroad, and achieved good reputation in the medical industry.
Becton, Dickinson and Company
BD provides medical devices and supplies, including povidone-iodine solutions for wound care.
Becton, Dickinson and Company
BD provides medical devices and supplies, including povidone-iodine solutions for wound care.
BSN Medical specializes in advanced wound care and offers a variety of adhesive bandages and dressings for different types of injuries.
Essity
BSN Medical specializes in advanced wound care and offers a variety of adhesive bandages and dressings for different types of injuries.
Smiths Medical specializes in medical devices and equipment, including ventilators and respiratory care products, to support patients and healthcare providers globally.
Smiths Group plc
Smiths Medical specializes in medical devices and equipment, including ventilators and respiratory care products, to support patients and healthcare providers globally.
Medline is a global healthcare company providing a wide range of medical products, including hospital beds and patient care solutions.
Medline Industries, Inc.
Medline is a global healthcare company providing a wide range of medical products, including hospital beds and patient care solutions.
Paul Hartmann AG is a German healthcare company that produces a variety of medical textiles, including surgical bed covers and disposable linens.
Paul Hartmann AG
Paul Hartmann AG is a German healthcare company that produces a variety of medical textiles, including surgical bed covers and disposable linens.
Halyard Health, formerly known as Kimberly-Clark Health Care, is a global medical technology company that produces surgical drapes and gowns designed to meet the highest standards of quality and safety.
Halyard Health, Inc.
Halyard Health, formerly known as Kimberly-Clark Health Care, is a global medical technology company that produces surgical drapes and gowns designed to meet the highest standards of quality and safety.
McKesson is a global leader in healthcare supply chain management, retail pharmacy, medical and surgical supply distribution.
McKesson Corporation
McKesson is a global leader in healthcare supply chain management, retail pharmacy, medical and surgical supply distribution.
Mölnlycke HealthCare is a leading provider of wound care and operating room products, including adhesive tapes and other medical devices.
Mölnlycke HealthCare AB
Mölnlycke HealthCare is a leading provider of wound care and operating room products, including adhesive tapes and other medical devices.
Baxter International Inc.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute, and in-center dialysis.
Baxter International Inc.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute, and in-center dialysis.
Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.
Cardinal Health, Inc.
Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.
A multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Johnson & Johnson
A multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Fresenius Kabi (China) Investment Co., Ltd.
Fresenius Cabi is a global enterprise focusing on the fields of infusion, blood transfusion and clinical nutrition. Fresenius Cabi provides reliable medical guarantees for patients with severe and chronic diseases with high-quality medicines, medical devices and services. Fresenius Cabi ’s product range includes intravenous medications, infusion therapy, clinical nutrition, and the medical devices required to apply these products. In the field of biosimilars, Fresenius Cabi focuses on autoimmune diseases and oncology. In terms of blood transfusion medicine and cell therapy devices, Fisseus Cabi provides blood component collection and in vitro cell therapy products. Taking care of life as its mission, Ferseniusca is committed to providing medical staff with essential medicines and technologies and helping them find quality solutions to solve problems. Since entering China, Fresenius Cabi has always regarded "caring for life" as the driving force for continuous development and progress, and is committed to helping the Chinese people improve their health and quality of life. Rooted in China for more than 30 years, Fresenius Cabi has been engaged in medicines, clinical nutrition, medical devices and other fields, thanks to its excellent products and technologies, standardized management, professional services, and efficient operation of R&D, production and marketing systems.业务领域取得骄人业绩，并发展成为中国临床营养、肾病营养治疗和麻醉治疗领域的领导者之一。
Fresenius Kabi (China) Investment Co., Ltd.
Fresenius Cabi is a global enterprise focusing on the fields of infusion, blood transfusion and clinical nutrition. Fresenius Cabi provides reliable medical guarantees for patients with severe and chronic diseases with high-quality medicines, medical devices and services. Fresenius Cabi ’s product range includes intravenous medications, infusion therapy, clinical nutrition, and the medical devices required to apply these products. In the field of biosimilars, Fresenius Cabi focuses on autoimmune diseases and oncology. In terms of blood transfusion medicine and cell therapy devices, Fisseus Cabi provides blood component collection and in vitro cell therapy products. Taking care of life as its mission, Ferseniusca is committed to providing medical staff with essential medicines and technologies and helping them find quality solutions to solve problems. Since entering China, Fresenius Cabi has always regarded "caring for life" as the driving force for continuous development and progress, and is committed to helping the Chinese people improve their health and quality of life. Rooted in China for more than 30 years, Fresenius Cabi has been engaged in medicines, clinical nutrition, medical devices and other fields, thanks to its excellent products and technologies, standardized management, professional services, and efficient operation of R&D, production and marketing systems.业务领域取得骄人业绩，并发展成为中国临床营养、肾病营养治疗和麻醉治疗领域的领导者之一。
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
ConvaTec (China) Medical Products Co., Ltd.
Conveyor is an international company focused on providing medical products and technologies for the treatment of chronic diseases. Conveyor is in an advanced position in the industry in the fields of wound care, ostomy care, incontinence management and intensive care, and infusion equipment. The company's products provide a range of clinical and economic benefits in fighting infections, protecting problem skin, improving patient healing effects and reducing the cost of treatment care.
ConvaTec (China) Medical Products Co., Ltd.
Conveyor is an international company focused on providing medical products and technologies for the treatment of chronic diseases. Conveyor is in an advanced position in the industry in the fields of wound care, ostomy care, incontinence management and intensive care, and infusion equipment. The company's products provide a range of clinical and economic benefits in fighting infections, protecting problem skin, improving patient healing effects and reducing the cost of treatment care.
Smith Medical Devices (Beijing) Co., Ltd.
ICU Medical was founded in 1984 and is headquartered in San Clemente, California. In 1992, the company issued its initial public offering of shares on Nasdaq (NASDAQ:ICUI). ICU Medical's main customers include: hospital emergency departments, wholesalers, mobile clinics, outpatient clinics, home health care and long-term care supply institutions, etc. Since its establishment, ICU company has maintained organic growth and extended its business to more than 90 countries and regions around the world through acquisitions. After more than 30 years of development, ICU Medical has now become one of the world's advanced infusion therapy companies (pure-play infusion therapy companies), with business covering more than 90 countries and regions around the world. The company's products include infusion solutions, smart infusion pumps, dedicated and non-special infusion kits and needle-free connectors, as well as pain management and safety software technologies designed to help achieve clinical, safety and workflow goals. In addition, ICU also manufactured the world's first needle-free automated infusion dispensing system with its advanced workflow technology, closed system transmission equipment (for equipped with hazardous infusion drugs) and cardiac monitoring system. The current business composition ratio of ICU is about: infusion consumables account for 40%; infusion systems account for 30%, infusion solutions account for 25%, and intensive care accounts for 5%. Among them, infusion consumables mainly include: gravity equipment, needleless intravenous injection connectors, as well as closed system transmission equipment and special infusion consumables. The infusion system includes: large-capacity and outpatient intravenous injection pumps, special infusion sets, electronic medical record interactive security software and on-site services. Infusion solutions include: disinfection solutions, infusion irrigation solutions and some nutritional solutions. Intensive care includes: hemodynamic monitoring systems for evaluating patient blood flow status, advanced sensors and catheters, and pressure sensors. ICU Medical's medical consumables always account for a high proportion of its product portfolio, ensuring that the company has always had good financial indicators. ICU Medical has direct branches in North America (USA, Canada), South America (Argentina, Chile, Peru, Colombia), Europe, the United Kingdom, South Africa, Australia and other regions, including China, India, Russia, Central Asia, Dealer channels are set up in Nordic countries and regions. In terms of production, ICU Medical has 4 factories, including 3 in the United States and 1 in Costa Rica. Among them, ICU Medical's investment in the Costa Ri processing plant reached US$13.2 million. In addition to producing more than 800 venous devices, the plant also produces award-winning Plum 360 and LifeCare PCA infusion pumps.
Smith Medical Devices (Beijing) Co., Ltd.
ICU Medical was founded in 1984 and is headquartered in San Clemente, California. In 1992, the company issued its initial public offering of shares on Nasdaq (NASDAQ:ICUI). ICU Medical's main customers include: hospital emergency departments, wholesalers, mobile clinics, outpatient clinics, home health care and long-term care supply institutions, etc. Since its establishment, ICU company has maintained organic growth and extended its business to more than 90 countries and regions around the world through acquisitions. After more than 30 years of development, ICU Medical has now become one of the world's advanced infusion therapy companies (pure-play infusion therapy companies), with business covering more than 90 countries and regions around the world. The company's products include infusion solutions, smart infusion pumps, dedicated and non-special infusion kits and needle-free connectors, as well as pain management and safety software technologies designed to help achieve clinical, safety and workflow goals. In addition, ICU also manufactured the world's first needle-free automated infusion dispensing system with its advanced workflow technology, closed system transmission equipment (for equipped with hazardous infusion drugs) and cardiac monitoring system. The current business composition ratio of ICU is about: infusion consumables account for 40%; infusion systems account for 30%, infusion solutions account for 25%, and intensive care accounts for 5%. Among them, infusion consumables mainly include: gravity equipment, needleless intravenous injection connectors, as well as closed system transmission equipment and special infusion consumables. The infusion system includes: large-capacity and outpatient intravenous injection pumps, special infusion sets, electronic medical record interactive security software and on-site services. Infusion solutions include: disinfection solutions, infusion irrigation solutions and some nutritional solutions. Intensive care includes: hemodynamic monitoring systems for evaluating patient blood flow status, advanced sensors and catheters, and pressure sensors. ICU Medical's medical consumables always account for a high proportion of its product portfolio, ensuring that the company has always had good financial indicators. ICU Medical has direct branches in North America (USA, Canada), South America (Argentina, Chile, Peru, Colombia), Europe, the United Kingdom, South Africa, Australia and other regions, including China, India, Russia, Central Asia, Dealer channels are set up in Nordic countries and regions. In terms of production, ICU Medical has 4 factories, including 3 in the United States and 1 in Costa Rica. Among them, ICU Medical's investment in the Costa Ri processing plant reached US$13.2 million. In addition to producing more than 800 venous devices, the plant also produces award-winning Plum 360 and LifeCare PCA infusion pumps.
Nipro Trading (Shanghai) Co., Ltd.
NIPRO is at the forefront of global medical care and constantly challenges the unknown areas of life sciences. With persistent commitment to the research and development and innovation of cutting-edge medical products, NIPRO has been able to provide excellent technologies and products for various fields such as medical equipment and medicines. A variety of patented technologies used in artificial kidneys and various disposable medical devices give this medical product unprecedented functions and characteristics. NIPRO has also carried out close cooperation with many multinational pharmaceutical companies (Pfizer, Novartis, Astra Zeneca, Takeda, Astellas, etc.), and through the design and optimization of the original dosage form, the bioavailability and safety of the drug are improved. The cooperation areas cover professional fields such as tumors, respiratory, kidney disease, rare diseases, anti-infection, and mental illness. The persistent pursuit of product quality has made NIPRO highly evaluated in the global clinical medical field. Especially in the fields of nephrological artificial organs and regenerative medicine, NIPRO has become a world-leading brand. Nipulo Trading (Shanghai) Co., Ltd. was officially established in Shanghai in 2003. It is mainly engaged in the sales of Nipro related products in the Chinese market. NIPRO has gained the trust and support of more and more clinical experts with its high-quality products and continuous improvement services. China in the early 1990s lacked foreign currency, and it was very difficult to buy dialysis machines and dialyzers from Japan at the same time. Nipulo Shanghai Contact Office (the predecessor of Nipulo Trading (Shanghai) Co., Ltd.) has helped China clinically carry out dialysis treatment since 1993, and has given dialysis machines to 10 Chinese hospitals for free, so many patients were treated, which also made the hospital. Saved a lot of money.
Nipro Trading (Shanghai) Co., Ltd.
NIPRO is at the forefront of global medical care and constantly challenges the unknown areas of life sciences. With persistent commitment to the research and development and innovation of cutting-edge medical products, NIPRO has been able to provide excellent technologies and products for various fields such as medical equipment and medicines. A variety of patented technologies used in artificial kidneys and various disposable medical devices give this medical product unprecedented functions and characteristics. NIPRO has also carried out close cooperation with many multinational pharmaceutical companies (Pfizer, Novartis, Astra Zeneca, Takeda, Astellas, etc.), and through the design and optimization of the original dosage form, the bioavailability and safety of the drug are improved. The cooperation areas cover professional fields such as tumors, respiratory, kidney disease, rare diseases, anti-infection, and mental illness. The persistent pursuit of product quality has made NIPRO highly evaluated in the global clinical medical field. Especially in the fields of nephrological artificial organs and regenerative medicine, NIPRO has become a world-leading brand. Nipulo Trading (Shanghai) Co., Ltd. was officially established in Shanghai in 2003. It is mainly engaged in the sales of Nipro related products in the Chinese market. NIPRO has gained the trust and support of more and more clinical experts with its high-quality products and continuous improvement services. China in the early 1990s lacked foreign currency, and it was very difficult to buy dialysis machines and dialyzers from Japan at the same time. Nipulo Shanghai Contact Office (the predecessor of Nipulo Trading (Shanghai) Co., Ltd.) has helped China clinically carry out dialysis treatment since 1993, and has given dialysis machines to 10 Chinese hospitals for free, so many patients were treated, which also made the hospital. Saved a lot of money.
B. Braun offers a comprehensive range of surgical instruments, including bone-cutting tools, known for their precision and durability.
B. Braun Melsungen AG
B. Braun offers a comprehensive range of surgical instruments, including bone-cutting tools, known for their precision and durability.
